Invention Grant
- Patent Title: Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease
- Patent Title (中): A2B腺苷受体拮抗剂治疗炎症性肠病
-
Application No.: US11982817Application Date: 2007-11-05
-
Publication No.: US08193200B2Publication Date: 2012-06-05
- Inventor: Shanthi V. Sitaraman , Joel M. Linden , Guoquan Wang , Robert Douglas Thompson , Jayson M. Rieger
- Applicant: Shanthi V. Sitaraman , Joel M. Linden , Guoquan Wang , Robert Douglas Thompson , Jayson M. Rieger
- Applicant Address: US VA Charlottesville US GA Atlanta
- Assignee: University of Virginia Patent Foundation,Emory University
- Current Assignee: University of Virginia Patent Foundation,Emory University
- Current Assignee Address: US VA Charlottesville US GA Atlanta
- Agency: Schwegman, Lundberg & Woesnner, P.A.
- Main IPC: A61K31/522
- IPC: A61K31/522 ; A61K31/496
Abstract:
The present invention relates to method for treating inflammatory bowel disease that includes administration of an effective amount of an antagonist of A2B adenosine receptors (ARs).
Public/Granted literature
- US20080176845A1 Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease Public/Granted day:2008-07-24
Information query
IPC分类:
